HC
CCXI

Henshaw Capital’s ChemoCentryx, Inc. CCXI Stock Holding History

Henshaw Capital’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,597
Closed -$287K – 366
2021
Q1 		$287K Buy
5,597
+1,242
+29% +$74.7K 0.02% 278
2020
Q4 		$270K Buy
4,355
+564
+15% +$32.3K 0.02% 276
2020
Q3 		$208K Buy
+3,791
New +$204K 0.02% 292

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $23.5B AUM 33.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Henshaw Capital's CCXI Position: Q2 2021 in Review

Henshaw Capital sold out of ChemoCentryx, Inc. (CCXI) in Q2 2021, closing a stake of 5,597 shares — an estimated $287K sold.

Henshaw Capital first reported a position in CCXI in Q3 2020 and held it in 3 quarters. The position peaked at $287K in Q1 2021. 147 funds tracked by Wall St. Rank hold CCXI as of Q2 2021.

  • Henshaw Capital reported no remaining ChemoCentryx, Inc. position as of Q2 2021 after selling out during the quarter.
  • Henshaw Capital sold 5,597 ChemoCentryx, Inc. shares in Q2 2021, an estimated $287K.
  • Henshaw Capital first reported a position in ChemoCentryx, Inc. in Q3 2020 and held it in 3 quarters.
  • Henshaw Capital's ChemoCentryx, Inc. position peaked at $287K in Q1 2021.
  • 147 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2021.

Based on Henshaw Capital's 13F filing for Q2 2021, filed 28 May 2026.